Premature Rupture of Membranes Detection Kit

Rapid test for detection of insulin-like growth factor binding protein-1. Used for diagnosis of premature rupture of membranes during pregnancy.

A diagnostic test kit designed to detect fetal fibronectin in cervical samples to assess preterm birth risk. The kit helps identify pseudo-threatened preterm birth and provides scientific measurement for comprehensive evaluation of fetal health. It uses advanced detection methodology to distinguish between threatened preterm labor and false positives, reducing unnecessary clinical interventions.

Testing system for perinatal disease screening and risk assessment in pregnant women and newborns. Supports maternal-fetal health monitoring protocols.

Test for detection of fetal fibronectin in cervicovaginal secretions during pregnancy. Assists in assessment of preterm delivery risk in pregnant women.

A diagnostic product designed to support female reproductive health and safety from pre-pregnancy through delivery, providing comprehensive testing solutions throughout the reproductive journey.

An in vitro diagnostic kit suitable for enzyme immunoassay analyzers, used for clinical in vitro detection of anti-trophoblast membrane antibody IgG in human serum. Available in specifications of 48 tests/box and 96 tests/box. Detection method: ELISA.

An ultrasound-based diagnostic test kit for detecting cervical insufficiency and fetal fibronectin to identify risk of preterm birth. The kit combines two detection items in one test to comprehensively assess pregnancy health. It helps distinguish between threatened preterm birth and pseudo-threatened preterm birth, with fFN testing providing high specificity for predicting actual preterm delivery risk.

Diagnostic test kit designed for assessment of maternal and neonatal health biomarkers during pregnancy and postpartum periods. Supports prenatal and pediatric health monitoring.

Rapid immunochromatographic assay for qualitative detection of human chorionic gonadotropin. Point-of-care test for pregnancy confirmation.

A detection kit measuring placental growth factor (PlGF) and soluble fms-like tyrosine kinase-1 (sFlt-1) using magnetic microparticle chemiluminescence methodology. These two biomarkers together form a comprehensive preeclampsia screening and prevention solution for the entire pregnancy period, with the kit being used in early pregnancy assessment as part of multiple factor screening protocols.

Molecular diagnostic kit for screening pregnant women and newborns for infectious diseases and genetic conditions. Supports prenatal and perinatal health monitoring programs.

This kit is suitable for qualitative detection of fetal fibronectin (fFN) in pregnant women's vaginal secretions. It is clinically used for auxiliary detection of preterm labor.